Sana Biotechnology SANA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$2.12M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 46.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 14.22% to 13.56% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Morgan Stanley | Public Company | 2026/Q3 | +1,882,589 | 1.0% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,882,589 | 1.0% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +249,084 | 0.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +235,751 | 2.9% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +211,482 | 0.1% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +190,400 | 0.5% |
| Putnam LLC | Mutual Fund | 2026/Q3 | +133,350 | 0.0% |
| Putnam Fiduciary Trust Company | Private Company | 2026/Q3 | +123,636 | 0.0% |
| Putnam LLC | Mutual Fund | 2026/Q3 | +130,655 | 0.0% |
| Putnam Fiduciary Trust Company | Private Company | 2026/Q3 | +124,492 | 0.0% |
| Dhavalkumar Patel | Individual/Insider | 2026/Q3 | +83,842 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +347,599 | 0.1% |
| Riverbridge Partners, LLC | Mutual Fund | 2026/Q3 | +152,878 | 0.1% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +18,750,000 | 6.3% |
| Bank of America Corporation | Public Company | 2026/Q3 | +2,794,012 | 1.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 4 Oct 2026 | Hans Edgar Bishop | Independent Chairperson | Other Acquisition | +8,680 | – | 5,863,480 |
| 26 Aug 2026 | Dhavalkumar Patel | Chief Scientific Officer | Derivative Exercise and Sale | -41,158 | $4.11 | 183,352 |
| 25 Aug 2026 | Dhavalkumar Patel | Chief Scientific Officer | Derivative Exercise and Retained | +83,842 | – | 183,352 |
| 5 Jul 2026 | Hans Edgar Bishop | Independent Chairperson | Other Acquisition | +6,297 | – | 5,854,800 |
| 3 Jun 2026 | Robert Taylor Nelsen | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Yuhmin Yang | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Michelle Seitz | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Richard Mulligan | Vice Chairperson | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Hans Edgar Bishop | Independent Chairperson | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Joshua Bilenker | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Alise Reicin | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 3 Jun 2026 | Robert Rosiello | Independent Director | Other Derivative Acquisition | +90,000 | $2.96 | 90,000 |
| 5 Apr 2026 | Hans Edgar Bishop | Independent Chairperson | Other Acquisition | +7,763 | – | 5,848,503 |
| 23 Mar 2026 | Dhavalkumar Patel | Chief Scientific Officer | Initial Statement of Beneficial | +0 | – | 1,396,250 |
| 8 Mar 2026 | Steven Harr | Chief Executive Officer | Derivative Exercise and Sale | -24,345 | $3.13 | 8,960,751 |
| 8 Mar 2026 | Susan Wyrick | Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting | Derivative Exercise and Sale | -4,387 | $3.13 | 196,196 |
| 6 Mar 2026 | Steven Harr | Chief Executive Officer | Derivative Exercise and Retained | +67,321 | – | 8,960,751 |
| 5 Mar 2026 | Susan Wyrick | Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting | Derivative Exercise and Retained | +9,279 | – | 196,196 |
| 4 Mar 2026 | Steven Harr | Chief Executive Officer | Other Derivative Acquisition | +200,000 | – | 200,000 |
| 4 Mar 2026 | Steven Harr | Chief Executive Officer | Other Derivative Acquisition | +900,000 | $3.41 | 900,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 40,600,271 | 13.6% | 15.8 |
| 15 Oct 2026 | 40,846,893 | 13.6% | 11.0 |
| 30 Sep 2026 | 38,725,699 | 12.9% | 9.0 |
| 15 Sep 2026 | 41,374,811 | 13.8% | 12.2 |
| 31 Aug 2026 | 41,563,334 | 13.9% | 16.1 |
| 14 Aug 2026 | 42,568,975 | 14.2% | 18.0 |
No comments yet — be the first to weigh in on SANA.
Sign in to join the discussion.